SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Italy Declares Novartis AG FLUAD Vaccine Safe; Results Still Waiting On Agrippal Flu Vaccine
December 2, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
European Commission (EC) Regulators Mull Novartis AG, GlaxoSmithKline Deals As January Deadline Looms
December 1, 2014
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Novartis AG Flu Vaccine FLUAD Suspended Following 13 Reported Deaths
December 1, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Fingolimod Ph3 Trial In PPMS Fails To Meet Primary Goal
December 1, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Novartis AG Fires Scientist Who Falsified Data In 6 Research Papers
November 25, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG’s Xolair To Treat Chronic Hives
November 19, 2014
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Babies Die While Officials Haggle With Novartis AG Over Cost Of Bexsero Vaccine
November 10, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Novartis AG’s Panobinostat Fails To Win FDA Panel Support
November 7, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Genmab A/S Moves Cancer Drug Pact To Novartis AG From GlaxoSmithKline
November 3, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Novartis Pharmaceuticals Corporation’ Afinitor Study Met Key Goal Of Tumor-size Reduction In TSC Patients
July 8, 2011
 · 
19 min read
FDA
FDA Approves Novartis Pharmaceuticals Corporation’s Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
July 1, 2011
 · 
2 min read
FDA
FDA Panel Rejects Novartis AG Drug for Gout
June 21, 2011
 · 
1 min read
Job Trends
Novartis AG Begins Construction of New State-Of-The-Art Pharmaceutical Manufacturing Plant in St. Petersburg, Russia, 350 New Jobs to be Created
June 17, 2011
 · 
1 min read
Policy
US FDA Staff - “Complicated” Data on Novartis AG Gout Drug
June 17, 2011
 · 
1 min read
Policy
Novartis AG Application for Expanded Menveo(R) Indication from 2 Months of Age Accepted for Review by FDA
June 16, 2011
 · 
8 min read
Policy
Watson Pharmaceuticals, Inc. Asks Approval to Market a Generic of Novartis AG’s Pataday
June 15, 2011
 · 
3 min read
Drug Development
Novartis AG Vaccine Shields Against Meningitis Cause
June 9, 2011
 · 
1 min read
Deals
As Gen-Probe Incorporated Suitors Pull Out, So Do Options Traders; Novartis AG Reported to be the Last One Standing
June 7, 2011
 · 
1 min read
Drug Development
Novartis AG Drug Gleevec(R) Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
June 6, 2011
 · 
10 min read
Load More